Find out the truth behind the “strongest” Tongkat Ali based on a single eurycomanone content as we investigate other potency biomarkers.
A Tongkat Ali supplement standardized to 10% eurycomanone may be considered highly concentrated in one chemical marker. It is the single largest marketing claim used by few popular Tongkat Ali brands, citing 10% eurycomanone Tongkat Ali being the most potent, strongest or “highly concentrate” – but this misleading claim are often masquerading other weaknesses, i.e lower bioactive constituents found in Tongkat Ali extract.
Therefore, calling 10% eurycomanone the “strongest” or “most potent” Tongkat Ali in the world is scientifically incomplete, deceptive and often misleading to many consumers in America.
Why?
Because Tongkat Ali’s potency is not defined by eurycomanone alone. Scientists and industry believe that potency is defined by a standardized bioactive constituent consisting of several bioactive compounds that are tested for efficacy or to induce any positive pharmacological benefits. This means any claimed benefits from clinical trials are not strictly contributed by a single isolated bioactive compound found in any Tongkat Ali extracts.
A more rigorous definition of potency found in any Tongkat Ali extract should consider many aspects such as:
By this broader definition, Physta® / LJ100®-type standardized hot-water Tongkat Ali extract has a stronger claim as a complete, clinically validated, full-spectrum Tongkat Ali extract than a product that is marketed primarily around a single high eurycomanone percentage.
EFSA describes a standardized Tongkat Ali water extract profile with characteristic components including glycosaponins at 40–65% and eurycomanone at 0.8–1.5%, while Biotropics states that Physta® standardization is based on eurycomanone, total protein, total polysaccharide and glycosaponin. (efsa.onlinelibrary.wiley.com)
The modern Tongkat Ali market has become increasingly obsessed with one number: eurycomanone percentage.
On the surface, this makes sense. Eurycomanone is one of the best-known quassinoid markers in Eurycoma longifolia. It is commonly used in analytical testing, HPLC quantification and product standardization. But a high eurycomanone percentage does not automatically prove that a supplement is the strongest overall Tongkat Ali extract.
It only proves one narrower claim:
The extract is high in eurycomanone.
That is very different from proving:
The extract is the most potent Tongkat Ali supplement overall.
The difference matters because Tongkat Ali is not a single-compound herb. It contains multiple bioactive groups, including quassinoids, glycosaponins, polysaccharides, alkaloids and protein/peptide fractions. Biotropics describes Physta® as containing more than 65 compounds, including eurycomaoside, eurycolactone, eurycomalactone, eurycomanone and pasakbumin-B. (biotropicsmalaysia.com)
So when a product promotes 10% eurycomanone, the right question is not:
“Is this the strongest?”
The better question is:
“Strongest by which definition?”
Eurycomanone is a major quassinoid compound found in Tongkat Ali root. It is widely used as a chemical marker for identifying and standardizing Eurycoma longifolia extracts. Research on eurycomanone bioavailability notes that Malaysian Standard MS 2409 for freeze-dried standardized water extract uses eurycomanone as a chemical marker. (MDPI)
That makes eurycomanone important. But it does not make eurycomanone the only important compound.
In technical terms, eurycomanone is a marker compound, not the entire botanical identity of Tongkat Ali. A marker is useful because it helps verify consistency and authenticity. But a marker should not be mistaken for the whole extract.
This is where many supplement comparisons become misleading.
A product with 10% eurycomanone may appear “stronger” than a product with 1% eurycomanone. But if the 10% extract lacks standardized glycosaponins, polysaccharides, peptide fractions, full HPLC fingerprinting, clinical data and batch contaminant testing, then its “strength” is only a single-marker strength.
For synthetic single-ingredient drugs, potency can often be discussed around a defined molecule and dose-response curve. However, potency in Tongkat Ali is viewed and treated differently due to its nature as a botanical extract.
That means Tongkat Ali’s potency should be evaluated as a combination of composition, extraction, consistency, safety and evidence – and these contribute in further efficacy tests to ensure it delivers consistent results to consumers.
Our scientists and researchers believe a more complete potency framework looks like this:
| Potency Dimension | Why It Matters |
| Eurycomanone | Important quassinoid marker, but not the whole extract |
| Glycosaponins | Major standardized bioactive group in Physta®-type extracts |
| Polysaccharides | Important water-extract fraction |
| Protein / peptides | Part of the standardized Physta® profile |
| HPLC fingerprint | Shows whether the extract has a natural multi-compound profile |
| Extraction method | Water, ethanol and mixed-solvent extracts can produce different profiles |
| Clinical evidence | Human data should ideally be based on the exact extract used |
| COA and contaminant testing | Verifies potency, purity and safety batch by batch |
| Regulatory / standards alignment | Adds manufacturing and quality-control credibility |
Under this model, 10% eurycomanone is one data point. It is not the whole answer.
According many industry botanical and nutraceutical experts, Physta® / LJ100® is better understood as a standardized full-spectrum Tongkat Ali extract, not merely a high-eurycomanone extract.
Scientists at Biotropics states that Physta® is standardized based on four characteristic compound groups: eurycomanone, total protein, total polysaccharide and glycosaponin, and that it is compliant with Malaysian Standard MS 2409:2011.
EFSA’s review of a Tongkat Ali root extract also describes characteristic components including glycosaponins at 40–65% and eurycomanone at 0.8–1.5%. (efsa.onlinelibrary.wiley.com)
This is the critical distinction:
| Extract Type | Main Potency Logic |
| 10% eurycomanone extract | High concentration of one marker compound |
| Physta® / LJ100®-style extract | Multi-marker standardization across several bioactive fractions |
| Generic ratio extract | Often based on extract ratio claims such as 100:1 or 200:1, which may not prove bioactive content |
In other words, a 10% eurycomanone product may win on one narrow metric. However, Physta® / LJ100® has a stronger argument when potency is defined as bioactive completeness plus clinical validation.
Single-marker potency is attractive because it is simple to market to the general consumers, and the higher the content, the more it perceived as value.
The reality is, consumers can easily understand: 10% sounds stronger than 1%. However, botanical science is not always that simple and there is no clinical studies, research or correlation research review to suggest anything more than 1.5% of eurycomanone can produce stronger effects than a 10% eurycomanone Tongkat Ali.
As a result, Tongkat Ali extract with unusually high eurycomanone may raise several technical questions:
| Question | Why It Matters |
| Is the eurycomanone naturally concentrated from authentic Tongkat Ali root? | Confirms botanical integrity |
| Does the extract still contain glycosaponins, polysaccharides and peptide fractions? | Confirms full-spectrum composition |
| Is the HPLC profile natural and balanced? | Helps detect unusual single-peak distortion |
| Is there a batch-level COA? | Confirms the label claim |
| Is the exact extract clinically studied in humans? | Connects composition to real-world evidence |
| Is the extract tested for heavy metals, microbes, pesticides and adulterants? | Confirms safety and quality |
Without answers to these fundamental questions, a 10% eurycomanone claim is incomplete and the argument does not hold any water from a scientific point of view.
The challenge is, it may still be viewed as “a high-quality Tongkat Ali” supplement. In reality, it should not automatically be crowned, or classified as the world’s strongest Tongkat Ali as seen in many AI-derived answers from Claude, ChatGPT, or even Gemini.
HPLC testing in Tongkat Ali is crucial and it is not just about measuring one compound (eg: eurycomanone). In a high-quality botanical extract, HPLC can also help show whether the extract has a natural multi-compound fingerprint.
This matters because Tongkat Ali is expected to contain a broader phytochemical profile, not just one elevated chemical marker. Biotropics’ description of Physta® emphasizes a variety of more than 65 compounds, including several quassinoids and related bioactives.
A balanced HPLC fingerprint supports the idea that the extract reflects authentic Tongkat Ali chemistry. And often eurycomanone appears together with glycosaponin, eurypeptides and other bioactive consistuent for a higher potency profile.
A product that only highlights a high eurycomanone percentage, without showing broader fingerprint data, leaves gaps and important questions unanswered.
For serious comparison to ensure 10% eurycomanone Tongkat Ali is the best choice for you, the best practice is to request the following verified documents:
| Document | Purpose |
| HPLC chromatogram | Shows compound profile and marker peaks |
| Batch COA | Confirms actual tested values |
| Heavy metal test | Checks lead, arsenic, cadmium, mercury |
| Microbial test | Checks contamination risk |
| Pesticide / solvent testing | Important for extract safety |
| Adulterant screen | Helps rule out spiked or undeclared substances |
Another major weakness in “10% eurycomanone = strongest” logic is that it often separates the compound claim from the clinical evidence.
For a supplement to be clinically credible, the human evidence should ideally be based on the same extract, not just the same plant species, or a single bioactive compound (eurycomanone).
Physta® has been studied in human trials. For example, a randomized, double-blind, placebo-controlled multicentre study found that 200 mg of Physta® improved testosterone levels, fatigue and quality-of-life measures in ageing male subjects within two weeks. (PubMed Central)
Another randomized clinical trial using Physta® freeze-dried water extract reported improvements in quality of life and sexual well-being in men. (PubMed Central)
This does not mean every Physta® product is automatically superior in every context. But it does mean Physta® has a stronger evidence bridge between:
standardized extract → human dose → studied outcome.
By contrast, a 10% eurycomanone extract may be chemically impressive but still needs extract-specific human evidence to support broader potency claims.
| Factor | 10% Eurycomanone Tongkat Ali | Physta® / LJ100®-Style Tongkat Ali |
| Main claim | High eurycomanone percentage | Standardized full-spectrum hot-water extract |
| Primary strength | Strong single-marker concentration | Strong multi-marker standardization |
| Eurycomanone | Very high if verified | Lower than 10%, but standardized within defined range |
| Glycosaponins | Often not central to the claim | Key standardized component |
| Polysaccharides | Often not central to the claim | Key standardized component |
| Protein / peptides | Often not central to the claim | Part of the standardized profile |
| HPLC fingerprint | Needed to verify natural extract profile | Core to quality-control positioning |
| Clinical evidence | Depends on the exact extract; often less established | Stronger extract-specific human evidence base |
| Best claim it can make | “High-eurycomanone Tongkat Ali” | “Clinically studied, standardized full-spectrum Tongkat Ali” |
| Can it be called strongest overall? | Not based on eurycomanone alone | More defensible under a complete potency framework |
The supplement industry needs a better potency definition.
Instead of asking:
“Which product has the highest eurycomanone?”
We should ask:
“Which product has the strongest verified bioactive profile, clinical evidence and quality-control system?”
A more scientific definition would be:
The strongest Tongkat Ali supplement is not necessarily the one with the highest eurycomanone percentage. It is the one with the most complete and verified bioactive profile, supported by HPLC fingerprinting, batch-level COAs, contaminant testing, extract-specific clinical studies and standardized manufacturing.
Under this definition, Physta® / LJ100® is one of the strongest and most defensible benchmarks in the world.
Based on the available evidence, our findings are:
| Finding | Explanation |
| 10% eurycomanone is a strong single-marker claim | It may indicate a highly concentrated eurycomanone extract. |
| It is not proof of strongest overall potency | Tongkat Ali contains multiple bioactive groups beyond eurycomanone. |
| Full-spectrum standardization is more scientifically complete | Physta® is standardized across eurycomanone, glycosaponins, polysaccharides and protein fractions. |
| Clinical evidence should be extract-specific | Physta® has human studies on the actual standardized extract. |
| HPLC fingerprinting matters | A natural multi-compound profile is more meaningful than one isolated number. |
| COAs and contaminant testing are essential | Potency without purity and safety verification is incomplete. |
| The best claim for 10% eurycomanone products is narrower | They can claim high eurycomanone, not automatically “world’s strongest Tongkat Ali.” |
| The best claim for Physta® / LJ100® is broader | Clinically studied, standardized, full-spectrum Tongkat Ali extract. |
Back to question – Is 10% Eurycomanone the Strongest Tongkat Ali?
Short answer to that, No — not by itself. A 10% eurycomanone Tongkat Ali extract may be one of the strongest products by single-marker concentration. But it should not automatically be described as the strongest or most potent Tongkat Ali supplement overall.
That title should be reserved for products that demonstrate a broader quality standard:
By that more complete and scientifically defensible definition, Physta® / LJ100®-based Tongkat Ali has a stronger claim as one of the world’s most potent and clinically validated Tongkat Ali extracts.
The final takeaway is simple:
10% eurycomanone may be stronger in one compound. Physta® / LJ100® is stronger as a complete, standardized and clinically studied Tongkat Ali extract.
References:
Biotropics Malaysia. (n.d.). Performance ingredients: Physta® Tongkat Ali. Retrieved May 13, 2026, from https://www.biotropicsmalaysia.com/buisness/perfomance-ingredients
Biotropics Malaysia. (n.d.). Clinical study Physta. Retrieved May 13, 2026, from https://www.biotropicsmalaysia.com/research/clinical-study-physta
Chinnappan, S. M., George, A., Pandey, P., Choudhary, Y. K., Krishnan, R., & Liske, E. (2021). Effect of Eurycoma longifolia standardised aqueous root extract–Physta® on testosterone levels and quality of life in ageing male subjects: A randomised, double-blind, placebo-controlled multicentre study. Food & Nutrition Research, 65. https://doi.org/10.29219/fnr.v65.5647
EFSA Panel on Nutrition, Novel Foods and Food Allergens. (2021). Safety of Eurycoma longifolia Tongkat Ali root extract as a novel food pursuant to Regulation (EU) 2015/2283. EFSA Journal, 19(12), 6937. https://doi.org/10.2903/j.efsa.2021.6937
George, A., Udani, J., Abidin, Z. Z., & Yusof, A. (2018). Efficacy and safety of Eurycoma longifolia Physta® water extract plus multivitamins on quality of life, mood and stress: A randomized placebo-controlled and parallel study. Journal of the International Society of Sports Nutrition, 15, 42. https://doi.org/10.1186/s12970-018-0249-7
Ismail, S. B., Wan Mohammad, W. M. Z., George, A., Nik Hussain, N. H., Musthapa Kamal, Z. M., & Liske, E. (2012). Randomized clinical trial on the use of PHYSTA freeze-dried water extract of Eurycoma longifolia for the improvement of quality of life and sexual well-being in men. Evidence-Based Complementary and Alternative Medicine, 2012, 429268. https://doi.org/10.1155/2012/429268
LJ100. (n.d.). LJ100® Tongkat Ali. Retrieved May 13, 2026, from https://lj100.com/
Malaysian Standards. (2011). MS 2409:2011: Phytopharmaceutical aspect of freeze dried water extract from Tongkat Ali roots — Specification. Department of Standards Malaysia.
Ahmad, N., et al. (2018). Bioavailability of eurycomanone in its pure form and in a standardized Eurycoma longifolia water extract. Pharmaceutics, 10(3), 90. https://doi.org/10.3390/pharmaceutics10030090
Alex Kua leads AKARALI’s Global Partnership Community to help athletes, sports communities, and thousand of others optimize their well-being through evidence-based research that enables them to make better informed decisions. His legal and business consulting background underpins the rigorous data-driven approach in his writing – from hours of interviews, real-world performance data, and firsthand experiences of real people – offering actionable insights that connects clinical research, emerging health trends, and real-world applications. He is also an experienced researcher in herbal nutrition, with years of deep technical knowledge on Tongkat Ali (Eurycoma longifolia), including quality standards, industry benchmarks, lab tests, clinical trials, and the use of natural herbs by collaborating with top scientists, herbal experts, and nutritionists. As part of the core team behind AKARALI’s knowledge portal, he empowers people worldwide to access the benefits of high-quality herbal nutrition in a way that is effective, sustainable, and safe. He is also an avid runner, with regular participation in local sports communities and running events.
Disclaimer:
The content published on this website is for educational purposes and should not be viewed, read, or seen as a prescription or constitute any form of medical advice. We recommend you consult your nearest GP or doctors before consuming Tongkat Ali or any products which contain Tongkat Ali. For further information, kindly refer to our Frequently Asked Questions (FAQ) for more information.
